Posted on 11/7/19
Mendix CEO Derek Roos Honored as 'CxO of the Year'
Mendix, a Siemens business and the global leader in low-code and no-code application development for the enterprise, today announced that Derek Roos, co-founder and chief executive . . .
Posted on 11/7/19
apiphani Appoints Cynthia Borgman to Board
apiphani, the global leader in automated mission critical application management, today announced that Cynthia Borgman, currently Chief Delivery Officer,
Posted on 11/6/19
riskmethods Names Patrik Heider CEO
riskmethods, a global leader in supply chain risk management, has announced the hiring of Patrik Heider as the company’s first Chief Executive Officer, joining riskmethods in . . .
Posted on 11/5/19
Pulmatrix Appoints Rick Batycky to Board
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary
Posted on 11/5/19
X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel
CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced . . .
Posted on 11/5/19
Cerevel Therapeutics Appoints Gabrielle Sulzberger to Board
Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that it has added Gabrielle Sulzberger
Posted on 11/3/19
Creatio CEO Katherine Kostereva Recognized in Top 50 Women Leaders in SaaS
Creatio (formerly bpm'online), a leading low-code, process automation and CRM company, is excited to announce that its CEO and Managing Partner Katherine Kostereva was named one . . .
Posted on 11/3/19
ASA Gold and Precious Metals Appoints Anthony Artabane to Board
PORTLAND, Maine--(BUSINESS WIRE)--ASA Gold and Precious Metals Limited (NYSE: ASA) announced that Director Gary Glynn has resigned from the Board of Directors, and Mr. Anthony J. Artabane . . .
Posted on 10/31/19
Localytics CEO Jude McColgan Selected to Participate in Digital Marketing Summit
BOSTON--(BUSINESS WIRE)--Localytics, a digital intelligence platform for mobile and web engagement, today announced that CEO Jude McColgan will participate as a discussion leader at LUMA's 5th . . .
Posted on 10/31/19
Bicycle Therapeutics Appoints Veronica Jordan, Ph.D., To Board
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology
Posted on 10/30/19
Progress Appoints Vivian Vitale to Board of Directors
Progress (NASDAQ: PRGS), the leading provider of application development and digital experience technologies, today announced the appointment of Vivian Vitale
Posted on 10/30/19
Vedanta Biosciences CEO Receives 2019 Immigrant Entrepreneur Award
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on defined bacterial consortia, is pleased to announce that . . .
Posted on 10/30/19
Third Pole Therapeutics Appoints Bill Athenson as CEO
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson
Posted on 10/30/19
Generation Bio Appoints Steven Dowdy, Ph.D., to its Scientific Advisory Board
Generation Bio, a company working to expand the reach of gene therapy through a novel construct and targeted delivery, today announced that Steven Dowdy, Ph.D.,
Posted on 10/29/19
Kimberly Ross Appointed to Cigna Board of Directors
Cigna Corporation (NYSE:CI) today announced that Kimberly A. Ross has been appointed to Cigna's Board of Directors. Her appointment is effective June 1, 2020.
Posted on 10/29/19
Bicycle Therapeutics Appoints Nigel Crockett, Ph.D., As Chief Business Officer
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide . . .
Posted on 10/29/19
Synspira Therapeutics Appoints Dr. Alexey Margolin And Robert K. Coughlin To Board
Synspira Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with cystic fibrosis (CF) and other rare diseases,
Posted on 10/29/19
Berkshire Hills Elects J. Williar Dunlaevy as Board Chair
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) announced that its Board of Directors has unanimously elected J. Williar ("Bill") Dunlaevy to serve as its Chairman
Posted on 10/28/19
Protegrity Appoints Rick Farnell as CEO
Protegrity, the only data-first security solution to deliver comprehensive discovery and protection of sensitive enterprise data in motion, and at rest, today announced that Rick Farnell
Posted on 10/28/19
HiFiBiO Therapeutics Establishes World-Class Scientific Advisory Board
HiFiBiO Therapeutics, a pioneer in innovative biotherapeutics with a unique single-cell analytics platform for extensive immune profiling
Posted on 10/24/19
CBSET’s CEO Peter Markham Honored As ‘2019 Biomedical Research Business Leader’ by Massachusetts Society for Medical Research (MSMR)
LEXINGTON, Mass.--(BUSINESS WIRE)--CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, announced today that its co-founder, president and chief . . .
Posted on 10/24/19
Health Monitor Network CEO, Ken Freirich, Awarded DTC Innovator Award
Ken Freirich, CEO of Health Monitor Network (HMN), a leading direct-to-patient/patient-engagement company, has been named a 2019 DTC Innovator of the Year Award recipient.
Posted on 10/24/19
Sonde Health Appoints David Liu as CEO
Sonde Health Inc., a leading company developing a voice-based technology platform to measure health when a person speaks, today announced that David Liu has joined Sonde . . .
Posted on 10/23/19
Textron Elects Lionel L. Nowell III to Board of Directors
Textron Inc. (NYSE: TXT) announced that Lionel L. Nowell III has been elected to the company's Board of Directors,
Posted on 10/23/19
Avangrid Renewables Names Alejandro de Hoz CEO
ORANGE, Conn.--(BUSINESS WIRE)--Avangrid Renewables, LLC, a subsidiary of AVANGRID, Inc. (NYSE: AGR), announced today that Alejandro de Hoz, currently the company’s Vice President of Offshore Wind, . . .

